130 related articles for article (PubMed ID: 3193206)
1. Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.
Malamitsi J; Skarlos D; Fotiou S; Papakostas P; Aravantinos G; Vassilarou D; Taylor-Papadimitriou J; Koutoulidis K; Hooker G; Snook D
J Nucl Med; 1988 Dec; 29(12):1910-5. PubMed ID: 3193206
[TBL] [Abstract][Full Text] [Related]
2. Radiolabelled monoclonal antibodies in tumour diagnosis and therapy.
Kosmas C; Kalofonos HP; Epenetos AA
Dev Biol Stand; 1990; 71():93-102. PubMed ID: 2401391
[TBL] [Abstract][Full Text] [Related]
3. Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administration.
Ward BG; Mather SJ; Hawkins LR; Crowther ME; Shepherd JH; Granowska M; Britton KE; Slevin ML
Cancer Res; 1987 Sep; 47(17):4719-23. PubMed ID: 3621168
[TBL] [Abstract][Full Text] [Related]
4. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
[TBL] [Abstract][Full Text] [Related]
5. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies in ovarian tumor imaging.
Fotiou S; Skarlos D; Tserkezoglou A; Aravantinos G; Malamitsi J; Koutoulidis K
Eur J Gynaecol Oncol; 1988; 9(4):304-7. PubMed ID: 3391206
[TBL] [Abstract][Full Text] [Related]
7. Distribution and pharmacokinetics of radiolabeled monoclonal antibody OC 125 after intravenous and intraperitoneal administration in gynecologic tumors.
Haisma HJ; Moseley KR; Battaile A; Griffiths TC; Knapp RC
Am J Obstet Gynecol; 1988 Oct; 159(4):843-8. PubMed ID: 3177533
[TBL] [Abstract][Full Text] [Related]
8. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
Thédrez P; Saccavini JC; Nolibé D; Simoen JP; Guerreau D; Gestin JF; Kremer M; Chatal JF
Cancer Res; 1989 Jun; 49(11):3081-6. PubMed ID: 2720666
[TBL] [Abstract][Full Text] [Related]
10. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients.
Pimm MV; Perkins AC; Armitage NC; Baldwin RW
J Nucl Med; 1985 Sep; 26(9):1011-23. PubMed ID: 3861794
[TBL] [Abstract][Full Text] [Related]
11. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
[TBL] [Abstract][Full Text] [Related]
12. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
Larson SM
Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunodetection in patients with suspected ovarian cancer.
Pateisky N; Philipp K; Skodler WD; Czerwenka K; Hamilton G; Burchell J
J Nucl Med; 1985 Dec; 26(12):1369-76. PubMed ID: 4067639
[TBL] [Abstract][Full Text] [Related]
14. Antibody-guided diagnosis and therapy of malignant lesions.
Kalofonos HP; Stewart S; Epenetos AA
Int J Cancer Suppl; 1988; 2():74-80. PubMed ID: 3162448
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.
Chatal JF; Saccavini JC; Gestin JF; Thédrez P; Curtet C; Kremer M; Guerreau D; Nolibé D; Fumoleau P; Guillard Y
Cancer Res; 1989 Jun; 49(11):3087-94. PubMed ID: 2720667
[TBL] [Abstract][Full Text] [Related]
16. Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.
Kalofonos HP; Kosmas C; Hird V; Snook DE; Epenetos AA
Eur J Cancer; 1994; 30A(12):1842-50. PubMed ID: 7880616
[TBL] [Abstract][Full Text] [Related]
17. Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.
Epenetos AA; Munro AJ; Stewart S; Rampling R; Lambert HE; McKenzie CG; Soutter P; Rahemtulla A; Hooker G; Sivolapenko GB
J Clin Oncol; 1987 Dec; 5(12):1890-9. PubMed ID: 3681374
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal immunoconjugates.
Griffin TW; Collins J; Bokhari F; Stochl M; Brill AB; Ito T; Emond G; Sands H
Cancer Res; 1990 Feb; 50(3 Suppl):1031s-1038s. PubMed ID: 2404580
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
[TBL] [Abstract][Full Text] [Related]
20. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
J Nucl Med; 1998 Mar; 39(3):476-84. PubMed ID: 9529295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
